MASS. MOVERS

Genzyme slips as FDA sets decision date

January 22, 2010

E-mail|
Reprints|

Text size – +

Genzyme Corp. edged down after the Food and Drug Administration said it would make a decision on Genzyme’s Pompe disease drug Lumizyme by June 17. The FDA had refused to approve Lumizyme until Genzyme fixed manufacturing problems at its Allston facility. Some of the bioreactors at the plant contained a virus that slowed the production of the company’s drugs, which ... (Full article: 93 words)